Glass Lewis Recommends Voting for ECAT's Board Nominees, Rejects Activist Slate
ECAT is trading near its 52-week low of $13.36 (14% above the low).
Summary
BlackRock ESG Capital Allocation Term Trust announced that Glass Lewis, a key proxy advisory firm, recommended shareholders vote for the incumbent board nominees and against activist investor Saba Capital Management's slate, a significant development in the ongoing proxy battle.
Key Events · Corporate Governance and Compliance · ECAT
-
Glass Lewis Endorses Incumbent Board
Leading independent proxy advisory firm Glass Lewis recommended shareholders vote on the WHITE proxy card FOR all nine of BlackRock ESG Capital Allocation Term Trust's incumbent board nominees.
-
Activist Nominees Rejected
Glass Lewis explicitly rejected the full slate of nominees proposed by activist investor Saba Capital Management.
-
Saba Capital's Reduced Stake Noted
Glass Lewis highlighted that Saba Capital Management has sold down nearly a third of its stake in the Fund, potentially weakening its influence in the proxy contest.
-
Annual Meeting Scheduled
The annual meeting where shareholders will vote on the board nominees is scheduled for June 9, 2026.
Analysis · ECAT · Unknown
This filing is a critical development in the ongoing proxy battle between BlackRock ESG Capital Allocation Term Trust (ECAT) and activist investor Saba Capital Management. Glass Lewis, a leading independent proxy advisory firm, carries significant weight with institutional investors. Their recommendation to vote for the incumbent board and against Saba's nominees provides a strong endorsement for current management and could decisively sway the outcome of the June 9th annual meeting. The additional detail that Saba has reduced its stake further weakens the activist's position.
At the time of this filing, ECAT was trading at $15.23 on NYSE in the Unknown sector. The 52-week trading range was $13.36 to $17.14. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.